IDEAYA BIOSCIENCES, INC.
Ownership & governance
Executives 5Directors 7Avg age 62Avg tenure 5.5y
YH
Yujiro Hata
Chief Executive Officer
Age 51Since 2015-05-31Profile →
+11
Executives5
YH
Yujiro Hata→
Chief Executive Officer
Age 51Since 2015-05-31
JB
Joshua Bleharski→
Director of Finance/CFO
Age 51Since 2025-04-30
DB
Darrin Beaupre→
Chief Tech/Sci/R&D Officer
Age 59Since 2022-11-20
MW
Michael White→
Chief Tech/Sci/R&D Officer
Age 61Since 2021-10-31
PB
Paul A. Barsanti→
Chief Tech/Sci/R&D Officer
—Since 2023-02-28
Board of directors7
YH
Yujiro Hata→
Chairman
Age 51Since 2026-06-16
TR
Terry Rosen→
Chairman
Age 67—
JS
Jeffrey Stein→
Director/Board Member
Age 71Since 2015-09-30
SM
Scott Morrison→
Director/Board Member
Age 68Since 2018-06-30
WY
Wendy Yarno→
Director/Board Member
Age 71Since 2019-12-16
GH
Garret Hampton→
Director/Board Member
Age 60Since 2020-06-25
CM
Catherine Mackey→
Director/Board Member
Age 70Since 2022-04-04
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Fidelity Management & Research Co. LLC | 15.03 % | 13,172,103 |
| BlackRock Advisors LLC | 8.774 % | 7,689,636 |
| Janus Henderson Investors US LLC | 8.318 % | 7,290,553 |
| Capital Research & Management Co. (Global Investors) | 5.892 % | 5,163,543 |
| Baker Bros. Advisors LP | 4.503 % | 3,946,515 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Darrin Beaupre | Chief Tech/Sci/R&D Officer | 2022-11-20 | - |
| Joshua Bleharski | Director of Finance/CFO | 2025-04-30 | - |
| Michael White | Chief Tech/Sci/R&D Officer | 2021-10-31 | - |
| Paul A. Barsanti | Chief Tech/Sci/R&D Officer | 2023-02-28 | - |
| Terry Rosen | Chairman | — | - |
| Yujiro Hata | Chairman | 2026-06-16 | - |
| Yujiro Hata | Chief Executive Officer | 2015-05-31 | - |
| Catherine Mackey | Director/Board Member | 2022-04-04 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 52.38Range 31–65Analysts 13
31Mean 52.3865
- Strong buy 3
- Buy 11
- Hold 1
Broker actions40 of 121
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Stifel | Initiated | Buy | 48 | 2026-10-14 |
| Guggenheim | Maintained | Buy | 57 | 2026-09-09 |
| Citizens | Reiterated | Market Outperform | 42 | 2026-09-01 |
| Truist Securities | Maintained | Buy | 59 | 2026-08-05 |
| Wedbush | Maintained | Outperform | 60 | 2026-08-05 |
| RBC Capital | Maintained | Outperform | 48 | 2026-07-07 |
| Truist Securities | Maintained | Buy | 63 | 2026-07-07 |
| Wedbush | Reiterated | Outperform | 58 | 2026-06-12 |
| Wedbush | Reiterated | Outperform | 58 | 2026-06-02 |
| Mizuho | Maintained | Outperform | 50 | 2026-05-07 |
| Goldman Sachs | Maintained | Neutral | 35 | 2026-04-14 |
| Wells Fargo | Maintained | Overweight | 48 | 2026-04-14 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.